MedTrace Logo

Vaccination Against COVID-19 in Chronic Kidney Disease

NCT04743947 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-01-10

No results posted yet for this study

Summary

This is a prospective, multi-center, observational study that will enroll patients receiving dialysis (hemodialysis or peritoneal dialysis) or patients with kidney transplantation who will be vaccinated against COVID-19.

Conditions

  • Chronic Kidney Disease Stage 5 on Dialysis
  • Chronic Kidney Disease Stage 5 With Transplant
  • Vaccine Response Impaired

Interventions

OTHER

No intervention; observational study

no intervention

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04743947 on ClinicalTrials.gov